Text Registration
Copyright Title
Epigenetic Cancer Therapy, 1st Edition
Status
Published
on 27 Feb 2017
Year of Creation
2015
Copyright Claimant
Elsevier Inc
Registration Number
TX0008301226
on 27 Feb 2017Copyright Summary
The U.S. Copyright record (Registration Number: TX0008301226) dated 27 Feb 2017, pertains to an electronic file (eService) titled "Epigenetic Cancer Therapy, 1st Edition" created in 2015. The copyright holder is Elsevier Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Elsevier Inc.
Application Details
Registration Number
TX0008301226
Registration Date
2/27/2017
Year of Creation
2015
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Book, 721 p
First Publication Nation
Ireland
ISBN
9780128002063
Preexisting Material
permissioned materials
Notes
Rights Note: permissions@elsevier.com
Local Copyright Note: C.O. correspondence
Material Matter Claimed Note: some text, compilation of articles
Statements
Application Title Statement: Epigenetic Cancer Therapy, 1st Edition
Author Statement: Steven Gray Citizenship: Ireland Authorship: some text, compilation of articles
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.